New nasal spray aims to stop asthma Flare-Ups triggered by common cold
Disease control
Recruiting now
This study tests a nasal spray called RIG-101 in healthy people and those with asthma. First, it checks safety and tolerability. Then, asthma participants receive the spray daily and are exposed to a cold virus to see if it prevents asthma worsening. The trial is recruiting 82 ad…
Phase: PHASE1, PHASE2 • Sponsor: RIGImmune Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC